Asosiy kontentga oʻtish
Maqola

Beyond Viral Positivity: Molecular Biomarkers for Etiologic Stratification of Virus-Associated and Nonviral Cancers

Ali M. AtoomFaculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, JordanJasur RizaevDepartment of Public Health and Healthcare management, Rector, Samarkand State Medical University, Samarkand, UzbekistanDjamila Sh. PolatovaPareshkumar N. PatelK.V. JamunaDepartment of Forensic Science, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, IndiaLaxmidhar MaharanaDepartment of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, 751030, IndiaNeeraj BainsalUniversity Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, IndiaDivya SinghalCentre for Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India
2026en
Ochiq kirishOltin

Litsenziya: cc-by-nc-nd

ABI

Annotatsiya

Histologically similar cancers can arise through different etiological pathways, yet viral detection alone does not establish tumor-cell association, oncogenic activity, or ongoing viral dependence. This structured narrative review evaluated molecular biomarkers that distinguish viral-etiology subsets from test-negative or etiologically distinct malignancies and examined their etiological and clinical value across human tumor types and relevant tumor-derived models. The literature synthesis was organized around three intersecting domains: oncogenic viruses (HPV, EBV, HBV, HCV, Merkel cell polyomavirus, and KSHV), malignancies (head and neck, cervical, gastric, nasopharyngeal, hepatic, Merkel cell, and selected lymphoid cancers), and biomarkers (viral nucleic acids, transcripts and proteins, integration, host genomic and epigenomic alterations, transcriptomics, microRNAs, immune and metabolic signatures, and circulating markers). Selection prioritized comparative tumor studies with interpretable viral-status definitions and biologically relevant comparators. Comparative evidence was evaluated according to the definition of viral status, appropriateness of nonviral comparators, analytical reliability, biological specificity, discriminatory performance, mechanistic coherence, and independent validation. No meta-analysis was undertaken because of substantial clinical and methodological heterogeneity. Molecular separation was strongest for Merkel cell polyomavirus-positive versus virus-negative Merkel cell carcinoma, and less pronounced in hepatocellular carcinoma, where viral and nonviral etiologies overlap. HPV-associated oropharyngeal and EBV-associated gastric cancers showed intermediate, context-dependent separation. Direct viral markers are most informative when linked to malignant-cell localization, transcription, relevant integration or protein expression, and functional dependence. Host-derived and circulating signatures may add contextual or clinical information but rarely establish viral causation on their own. Etiological classification therefore requires cancer-specific, multimodal, independently validated strategies rather than binary viral positivity.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar